Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase 1 Study Of An Intravenously Administered Cyclin-Dependent Kinase Inhibitor In Patients With Advanced Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00147485
Recruitment Status : Terminated (See Detailed Description)
First Posted : September 7, 2005
Last Update Posted : August 18, 2008
Sponsor:
Information provided by:
Pfizer

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : August 2007
Actual Study Completion Date : August 2007
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):